Other OTC - Delayed Quote USD

Better Therapeutics, Inc. (BTTX)

0.0100 +0.0010 (+11.11%)
At close: April 26 at 3:53 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Total Revenue
--
--
--
8.0000
Cost of Revenue
--
--
--
682.0000
Gross Profit
--
--
--
-674.0000
Operating Expense
29,613.0000
38,262.0000
30,560.0000
6,331.0000
Operating Income
-29,613.0000
-38,262.0000
-30,560.0000
-6,323.0000
Net Non Operating Interest Income Expense
-1,951.0000
-1,491.0000
-185.0000
-100.0000
Other Income Expense
--
--
-9,743.0000
189.0000
Pretax Income
-31,564.0000
-39,753.0000
-40,488.0000
-6,234.0000
Tax Provision
9.0000
7.0000
-153.0000
153.0000
Net Income Common Stockholders
-31,573.0000
-39,760.0000
-40,335.0000
-7,894.0000
Diluted NI Available to Com Stockholders
-31,573.0000
-39,760.0000
-40,335.0000
-7,894.0000
Basic EPS
-1.10
-1.69
-3.11
-0.33
Diluted EPS
-1.10
-1.69
-3.11
-0.33
Basic Average Shares
29,318.4480
23,557.8460
12,982.4720
23,599.7180
Diluted Average Shares
29,318.4480
23,557.8460
12,982.4720
23,599.7180
Total Operating Income as Reported
-29,613.0000
-38,262.0000
-30,560.0000
-6,323.0000
Total Expenses
29,613.0000
38,262.0000
30,560.0000
6,331.0000
Net Income from Continuing & Discontinued Operation
-31,573.0000
-39,760.0000
-40,335.0000
-6,387.0000
Normalized Income
-31,573.0000
-39,760.0000
-30,628.8178
-6,524.9700
Interest Expense
1,951.0000
1,491.0000
185.0000
100.0000
Net Interest Income
-1,951.0000
-1,491.0000
-185.0000
-100.0000
EBIT
-29,613.0000
-38,262.0000
-40,303.0000
-6,134.0000
EBITDA
-26,499.0000
-35,533.0000
-38,684.0000
-6,059.0000
Reconciled Cost of Revenue
--
--
--
682.0000
Reconciled Depreciation
3,114.0000
2,729.0000
1,619.0000
75.0000
Net Income from Continuing Operation Net Minority Interest
-31,573.0000
-39,760.0000
-40,335.0000
-6,387.0000
Total Unusual Items Excluding Goodwill
--
--
-9,743.0000
189.0000
Total Unusual Items
--
--
-9,743.0000
189.0000
Normalized EBITDA
-26,499.0000
-35,533.0000
-28,941.0000
-6,248.0000
Tax Rate for Calcs
0.0002
0.0002
0.0000
0.0003
Tax Effect of Unusual Items
--
--
-36.8178
51.0300
12/31/2020 - 3/17/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CLNN Clene Inc.
0.3399
-1.90%
 
BLPH Bellerophon Therapeutics, Inc.
0.0554
+0.73%
 
ZVSA ZyVersa Therapeutics, Inc.
4.9900
-16.83%
 
RNAZ TransCode Therapeutics, Inc.
0.5499
+5.30%
 
SNTI Senti Biosciences, Inc.
0.2900
+4.05%
 
BCEL Atreca, Inc.
0.0800
-6.43%
 
CLDI Calidi Biotherapeutics, Inc.
0.1607
+0.44%
 
PXMD PaxMedica, Inc.
0.7398
+5.06%
 
QNRX Quoin Pharmaceuticals, Ltd.
0.6375
+1.21%
 
KTRA Kintara Therapeutics, Inc.
0.1488
-5.82%